A powerful new tool in the fight against HIV has arrived, but whether South Africa can afford it remains uncertain. The FDA’s recent approval of Lenacapavir, a biannual injectable HIV prevention drug, has sparked hope and debate.
THE MORNING BRIEF
A powerful new tool in the fight against HIV has arrived, but whether South Africa can afford it remains uncertain. The FDA’s recent approval of Lenacapavir, a biannual injectable HIV prevention drug, has sparked hope and debate.
00:00 / 09:22